โšกToday
โœจToday's leadA Lost Altdorfer Landscape Surfaces After 70 Years Privately Held๐ŸŽˆFor kidsChile's Atacama Desert bursts into its biggest flower display in decades๐ŸŒฟNatureSouth Carolina tract beside wildlife refuge to be permanently conservedโšฝSportsCade Cunningham scores 52 with no turnovers in Pistons double-overtime win๐ŸŽจCulture & ideasCoventry Cathedral's Medieval Glass Survives as 12,000 Digitized Fragments๐Ÿ”ฌScience & healthMIT Scientists Reprogram Immune Cells to Fight Cancer Inside the Body๐Ÿ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joined๐Ÿ›๏ธPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressure๐Ÿš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

First human trial in China cuts epilepsy seizures by 92.6 per cent

South China Morning Post 6 November 2026 3 min read

โฎ BeforeMany people with refractory epilepsy have seizures that existing medicines cannot control.
โœ… NowIn a first human trial in China, a chemogenetic approach cut seizures by 92.6 per cent.

In short

  • Around one-third of epilepsy patients worldwide do not respond to existing medications.
  • The first human trial of a chemogenetic approach reported a 92.6 per cent cut in seizures.
  • Traditional resection surgery can carry the risk of irreversible neurological damage.

Why it's good news

About a third of people with epilepsy do not respond to existing medicines, and surgery carries serious risks. This first human trial tested a chemogenetic approach, which uses drugs to switch targeted brain cells off. The work is at an early stage, so it will need wider testing before it reaches patients routinely.

Advertisement

From South China Morning Post

For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes. Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic. Around one-third of epilepsy patients worldwide are completely unresponsive to existing medications, while traditional craniotomy resection surgery often carries the risk of irreversible neurological...

Read the full story at South China Morning Post Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor